Nina Bhardwaj

44.6k total citations · 14 hit papers
332 papers, 27.6k citations indexed

About

Nina Bhardwaj is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Nina Bhardwaj has authored 332 papers receiving a total of 27.6k indexed citations (citations by other indexed papers that have themselves been cited), including 262 papers in Immunology, 111 papers in Oncology and 99 papers in Molecular Biology. Recurrent topics in Nina Bhardwaj's work include Immunotherapy and Immune Responses (201 papers), Immune Cell Function and Interaction (107 papers) and T-cell and B-cell Immunology (83 papers). Nina Bhardwaj is often cited by papers focused on Immunotherapy and Immune Responses (201 papers), Immune Cell Function and Interaction (107 papers) and T-cell and B-cell Immunology (83 papers). Nina Bhardwaj collaborates with scholars based in United States, France and India. Nina Bhardwaj's co-authors include Matthew L. Albert, Birthe Sauter, Ralph M. Steinman, Marie Larsson, Mansi Saxena, Loise M. Francisco, Madhav V. Dhodapkar, Sreekumar Balan, Rachel Lubong Sabado and Selin Somersan and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Nina Bhardwaj

325 papers receiving 27.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

1998 1.9k citations Nina Bhardwaj et al. profile →
Consequences of Cell Death

2000 1.1k citations Nina Bhardwaj et al. profile →
Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells

2001 1.1k citations Nina Bhardwaj et al. profile →
Therapeutic cancer vaccines

2021 1.1k citations Mansi Saxena, Nina Bhardwaj et al. profile →
Immature Dendritic Cells Phagocytose Apoptotic Cells via αvβ5 and CD36, and Cross-present Antigens to Cytotoxic T Lymphocytes

1998 1.0k citations Nina Bhardwaj et al. profile →
Critical Role for CD103+/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma

2016 729 citations Dusan Bogunovic, Nina Bhardwaj et al. profile →
Dendritic cell-based immunotherapy

2016 701 citations Rachel Lubong Sabado, Sreekumar Balan et al. profile →
Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine.

2001 665 citations Nina Bhardwaj et al. profile →
Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood

1996 593 citations Nina Bhardwaj et al. profile →
Efficient Presentation of Phagocytosed Cellular Fragments on the Major Histocompatibility Complex Class II Products of Dendritic Cells

1998 529 citations Nina Bhardwaj et al. profile →
Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature.

1994 510 citations Nina Bhardwaj et al. profile →
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells

1999 376 citations Nina Bhardwaj et al. profile →
Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium.

1993 345 citations Nina Bhardwaj et al. profile →
Vaccinia Virus Inhibits the Maturation of Human Dendritic Cells: A Novel Mechanism of Immune Evasion

1999 314 citations Nina Bhardwaj et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nina Bhardwaj United States	83	20.6k	8.2k	7.7k	2.6k	2.5k	332	27.6k
Reinhold Förster Germany	77	24.7k 1.2×	5.5k 0.7×	8.0k 1.1×	1.4k 0.5×	2.7k 1.1×	239	33.3k
Edgar G. Engleman United States	78	15.5k 0.8×	6.0k 0.7×	5.8k 0.8×	2.0k 0.8×	3.7k 1.5×	277	24.9k
Thomas J. Schall United States	75	15.7k 0.8×	4.3k 0.5×	10.3k 1.4×	3.5k 1.4×	2.9k 1.2×	185	25.8k
Martin Lipp Germany	71	20.5k 1.0×	5.1k 0.6×	7.6k 1.0×	1.5k 0.6×	2.2k 0.9×	190	27.2k
Ellis L. Reinherz United States	96	24.2k 1.2×	9.2k 1.1×	5.5k 0.7×	2.5k 1.0×	2.6k 1.0×	392	36.0k
Hans‐Georg Rammensee Germany	81	19.6k 1.0×	11.3k 1.4×	6.0k 0.8×	1.1k 0.4×	3.7k 1.5×	361	28.0k
Gerold Schuler Germany	84	25.1k 1.2×	7.8k 0.9×	7.7k 1.0×	1.1k 0.4×	2.4k 1.0×	355	33.0k
Bernhard Moser Switzerland	69	16.6k 0.8×	3.8k 0.5×	10.7k 1.4×	2.1k 0.8×	2.0k 0.8×	128	24.0k
Susan M. Kaech United States	65	19.6k 1.0×	4.6k 0.6×	6.0k 0.8×	1.1k 0.4×	3.1k 1.2×	123	24.8k
Jeffrey V. Ravetch United States	115	29.6k 1.4×	15.6k 1.9×	7.4k 1.0×	1.9k 0.7×	3.9k 1.5×	268	47.2k

Countries citing papers authored by Nina Bhardwaj

Since Specialization

Citations

This map shows the geographic impact of Nina Bhardwaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Bhardwaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Bhardwaj more than expected).

Fields of papers citing papers by Nina Bhardwaj

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina Bhardwaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Bhardwaj. The network helps show where Nina Bhardwaj may publish in the future.

Co-authorship network of co-authors of Nina Bhardwaj

This figure shows the co-authorship network connecting the top 25 collaborators of Nina Bhardwaj. A scholar is included among the top collaborators of Nina Bhardwaj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina Bhardwaj. Nina Bhardwaj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Withers, Henry, Junko Matsuzaki, Mark D. Long, et al.. (2025). mTOR inhibition modulates vaccine-induced immune responses to generate memory T cells in patients with solid tumors. Journal for ImmunoTherapy of Cancer. 13(3). e010408–e010408. 2 indexed citations

Mestrallet, Guillaume, Matthew Brown, Cansu Cimen Bozkus, & Nina Bhardwaj. (2023). Immune escape and resistance to immunotherapy in mismatch repair deficient tumors. Frontiers in Immunology. 14. 1210164–1210164. 43 indexed citations

McClain, Christopher B., et al.. (2021). MMP2 and TLRs modulate immune responses in the tumor microenvironment. JCI Insight. 6(12). 45 indexed citations

Finak, Greg, Leonard D’Amico, Nina Bhardwaj, et al.. (2021). New interpretable machine-learning method for single-cell data reveals correlates of clinical response to cancer immunotherapy. Patterns. 2(12). 100372–100372. 21 indexed citations

Tan, I‐Li, Raquel Duque do Nascimento Arifa, Harikrishna Rallapalli, et al.. (2020). CSF1R inhibition depletes tumor-associated macrophages and attenuates tumor progression in a mouse sonic Hedgehog-Medulloblastoma model. Oncogene. 40(2). 396–407. 49 indexed citations

Perumal, Deepak, Naoko Imai, Alessandro Laganà, et al.. (2019). Mutation-derived Neoantigen-specific T-cell Responses in Multiple Myeloma. Clinical Cancer Research. 26(2). 450–464. 59 indexed citations

Pavlick, Anna C., Ana-Belén Blázquez, Marcia Meseck, et al.. (2019). Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma. Cancer Immunology Research. 8(1). 70–80. 56 indexed citations

Kyi, Chrisann, Vladimir Roudko, Rachel Lubong Sabado, et al.. (2018). Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial. Clinical Cancer Research. 24(20). 4937–4948. 97 indexed citations

Balan, Sreekumar, Catharina Arnold‐Schrauf, Francesco Imperatore, et al.. (2018). Large-Scale Human Dendritic Cell Differentiation Revealing Notch-Dependent Lineage Bifurcation and Heterogeneity. Cell Reports. 24(7). 1902–1915.e6. 107 indexed citations

10.

Bozkus, Cansu Cimen, John P. Finnigan, John Mascarenhas, et al.. (2017). Immune Checkpoint Blockade Enhances Mutated Calreticulin-Induced T Cell Immunity in Myeloproliferative Neoplasms. Blood. 130. 384–384. 3 indexed citations

11.

Москаленко, Марина, Michael Pan, Yichun Fu, et al.. (2015). Requirement for Innate Immunity and CD90+ NK1.1− Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy. Cancer Immunology Research. 3(3). 296–304. 19 indexed citations

12.

Silva, Inês Pires da, Anne Gallois, Sonia Jiménez-Baranda, et al.. (2014). Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade. Cancer Immunology Research. 2(5). 410–422. 315 indexed citations

13.

Adams, Sylvia, Lina Kozhaya, Frank Martiniuk, et al.. (2012). Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer. Clinical Cancer Research. 18(24). 6748–6757. 184 indexed citations

14.

Jungbluth, Achim A., Maurizio DiLiberto, Xiangao Huang, et al.. (2011). MAGE-A Inhibits Apoptosis in Proliferating Myeloma Cells through Repression of Bax and Maintenance of Survivin. Clinical Cancer Research. 17(13). 4309–4319. 79 indexed citations

15.

Bogunovic, Dusan, Olivier Manches, Emmanuelle Godefroy, et al.. (2011). TLR4 Engagement during TLR3-Induced Proinflammatory Signaling in Dendritic Cells Promotes IL-10–Mediated Suppression of Antitumor Immunity. Cancer Research. 71(16). 5467–5476. 42 indexed citations

16.

O’Reilly, Kathryn, Melanie Warycha, Michael A. Davies, et al.. (2009). Phosphorylated 4E-BP1 Is Associated with Poor Survival in Melanoma. Clinical Cancer Research. 15(8). 2872–2878. 54 indexed citations

17.

Segura, Miguel F., Douglas Hanniford, Sílvia Menéndez, et al.. (2009). Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proceedings of the National Academy of Sciences. 106(6). 1814–1819. 451 indexed citations

18.

Minkis, Kira, Daniel G. Kavanagh, Galit Alter, et al.. (2008). Type 2 Bias of T Cells Expanded from the Blood of Melanoma Patients Switched to Type 1 by IL-12p70 mRNA–Transfected Dendritic Cells. Cancer Research. 68(22). 9441–9450. 46 indexed citations

19.

Bioley, Gilles, Philippe Guillaume, Immanuel F. Luescher, et al.. (2008). HLA Class I–Associated Immunodominance Affects CTL Responsiveness to an ESO Recombinant Protein Tumor Antigen Vaccine. Clinical Cancer Research. 15(1). 299–306. 15 indexed citations

20.

Bhardwaj, Nina & Marcus A. Horwitz. (1988). Interferon-γ and Antibiotics Fail to Act Synergistically to Kill Legionella pneumophila in Human Monocytes. Journal of Interferon Research. 8(3). 283–293. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact